About Acute Rheumatic Fever and Rheumatic Heart Disease
This site assists in the ongoing management and prevention of Acute Rheumatic Fever (ARF) of patients in the Northern Territory who have previously had Acute Rheumatic Fever (ARF) or currently have Rheumatic Heart Disease (RHD).
ARF can occur after streptococcal (strep) infection, which may affect the throat or skin. The immune system is confused by the strep germ and produces antibodies which attack tissues in the heart, joints, brain and rarely the skin.
RHD is damage to the heart valves caused by acute rheumatic fever.
Recurrences of ARF may cause further valve damage, leading to worsening RHD. Prevention of recurrences of ARF is therefore of great importance.
Prevention of ARF by 4-weekly* benzathine penicillin G (BPG) injections** is the only effective means to control RHD.
RHD management includes regular clinical follow-up with specialist review and echocardiography.
* Patients on the 4 weekly medications should have 13 needles per year. Some patients may be on 3 weekly benzathine penicillin G (BPG) injections, and require 17 injections per year.
About the Rheumatic Heart Disease Program
It is the aim of the Rheumatic Heart Disease (RHD) Program to reduce the recurrences of acute rheumatic fever and reduce the burden of RHD amongst the people of the Northern Territory. The RHD team will meet this challenge by working closely with people touched by this disease, their families and people from their community. The RHD team will work towards this aim through education, training and support of community members and health staff.